P M Barker
Overview
Explore the profile of P M Barker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
478
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mphatswe W, Mate K, Bennett B, Ngidi H, Reddy J, Barker P, et al.
Bull World Health Organ
. 2012 Mar;
90(3):176-82.
PMID: 22461712
Objective: To evaluate the effect of an intervention to improve the quality of data used to monitor the prevention of mother-to-child transmission (PMTCT) of the human immunodeficiency virus in South...
2.
Southern K, Barker P
Eur Respir J
. 2004 Nov;
24(5):834-8.
PMID: 15516680
During what is a relatively barren time for new therapies for cystic fibrosis (CF), azithromycin has received a lot of attention as a potential treatment for CF lung disease. Laboratory...
3.
Barker P, Esther Jr C, Fordham L, Maygarden S, Funkhouser W
Eur Respir J
. 2004 Sep;
24(3):413-9.
PMID: 15358700
Primary pulmonary lymphangiectasia (PPL) is a rare disorder of unknown aetiology characterised by dilatation of the pulmonary lymphatics. PPL is widely reported to have a poor prognosis in the neonatal...
4.
Southern K, Barker P, Solis A
Cochrane Database Syst Rev
. 2004 Apr;
(2):CD002203.
PMID: 15106170
Background: Chronic severe infection with Pseudomonas aeruginosa, affects many people with cystic fibrosis (CF). There is evidence from the laboratory and from other disease processes that macrolide antibiotics, whilst not...
5.
Southern K, Barker P, Solis A
Cochrane Database Syst Rev
. 2003 Aug;
(3):CD002203.
PMID: 12917924
Background: The antibiotic treatment of chest infections which characterise cystic fibrosis (CF) has significantly improved prospects for people with CF. The nature of organisms causing these infections has restricted antibiotic...
6.
Southern K, Funkhouser W, Kazachkova I, Godfrey V, Fordham L, Gatzy J, et al.
Eur J Clin Invest
. 2003 Jan;
32(12):956-61.
PMID: 12534457
Background: Airway surface liquid (ASL) is difficult to sample. Lavage with an immiscible perfluorocarbon (PFC) liquid to recover ASL was evaluated in cats. Materials And Methods: Six wild-type cats underwent...
7.
Watson A, Johnston A, Barker P, Youngson G, Bisset W, Mahomed A
J Pediatr Surg
. 2002 Jan;
37(1):83-6.
PMID: 11781993
Purpose: This study reviews the presentation and management of juvenile onset chronic inflammatory bowel disease and identifies changes in incidence of the disease over a 20-year period. Methods: This was...
8.
Kazachkov M, Lager J, Lipuma J, Barker P
Pediatr Pulmonol
. 2001 Sep;
32(4):338-40.
PMID: 11568995
We describe an 11-year-old girl with cystic fibrosis (CF) who presented with respiratory failure and Burkholderia cepacia bacteremia (cepacia syndrome). She survived her illness after aggressive treatment with parenteral antibiotics...
9.
Southern K, Noone P, Bosworth D, LeGrys V, Knowles M, Barker P
J Pediatr
. 2001 Sep;
139(3):353-8.
PMID: 11562613
Objective: To establish a method for measuring nasal transepithelial potential difference (PD) in infants. Study Design: A modified infant method (smaller catheter size, reduced flow rates, and shorter protocol time)...
10.
Gillie D, Pace A, Coakley R, Koller B, Barker P
Am J Respir Cell Mol Biol
. 2001 Jul;
25(1):14-20.
PMID: 11472970
Chloride (Cl(-)) movement across fetal lung epithelia is thought to be mediated by the sodium-potassium-2-Cl(-) cotransporter NKCC1. We studied the role of NKCC1 in Cl(-) and liquid secretion in late-gestation...